Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    10465168 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels
Condition: Dyslipidemia
Intervention: Other: VASCAZEN
2 Completed Method of Fish Oil Administration on Patient Compliance
Condition: Adverse Effects
Interventions: Dietary Supplement: Frozen capsule;   Dietary Supplement: Capsule with food;   Dietary Supplement: Capsule without food;   Dietary Supplement: Capsule with milk

Indicates status has not been verified in more than two years